{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:57:07Z","timestamp":1787763427104,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejvs.2024.07.016","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T20:02:54Z","timestamp":1721073774000},"page":"619-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-0037","authenticated-orcid":false,"given":"Xiao","family":"Di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-8288","authenticated-orcid":false,"given":"Leng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.07.016_bib1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.016_bib2","first-page":"A141","article-title":"The incidence and health economic burden of ischemic amputation in Minnesota, 2005\u20132008","volume":"8","author":"Peacock","year":"2011","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ejvs.2024.07.016_bib3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/diagnostics11101736","article-title":"Recent updates and advances in Winiwarter-Buerger disease (thromboangiitis obliterans): biomolecular mechanisms, diagnostics and clinical consequences","volume":"11","author":"Fazeli","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ejvs.2024.07.016_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","article-title":"Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb","volume":"348","author":"Isner","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.07.016_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1586\/14779072.2014.955850","article-title":"Beperminogene perplasmid for the treatment of critical limb ischemia","volume":"12","author":"Suda","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib6","article-title":"Growth factors for angiogenesis in peripheral arterial disease","volume":"6","author":"Gorenoi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2024.07.016_bib7","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2024.07.016_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2024.07.016_bib9","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","year":"2023"},{"key":"10.1016\/j.ejvs.2024.07.016_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/gt.2015.110","article-title":"Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia","volume":"23","author":"Kibbe","year":"2016","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/gt.2010.51","article-title":"Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia","volume":"17","author":"Shigematsu","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jvs.2010.07.044","article-title":"Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial","volume":"52","author":"Powell","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.016_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","article-title":"Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia","volume":"118","author":"Powell","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.07.016_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/hum.2020.290","article-title":"pUDK-HGF gene therapy to relieve CLI rest pain and ulcer: a phase II, double-blind, randomized placebo-controlled trial","volume":"32","author":"Gu","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib15","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ymthe.2019.10.017","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase II study of hepatocyte growth factor in the treatment of critical limb ischemia","volume":"27","author":"Gu","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1024\/0301-1526\/a000298","article-title":"Gene therapy for therapeutic angiogenesis in peripheral arterial disease: a systematic review and meta-analysis of randomized, controlled trials","volume":"42","author":"Hammer","year":"2013","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2024.07.016_bib18","article-title":"Gene therapy for peripheral arterial disease","volume":"10","author":"Forster","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6S","key":"10.1016\/j.ejvs.2024.07.016_bib19","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.016_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.23736\/S0392-9590.22.04933-1","article-title":"International Union of Angiology position statement on no-option chronic limb threatening ischemia","volume":"41","author":"Troisi","year":"2022","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2024.07.016_bib21","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer","volume":"40","author":"Fitridge","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.016_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2024.07.016_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000136394.08900.ed","article-title":"Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease","volume":"44","author":"Morishita","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejvs.2024.07.016_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/ATVBAHA.110.219550","article-title":"Phase I\/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia","volume":"31","author":"Morishita","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2024.07.016_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jgm.1614","article-title":"A\u00a0phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia","volume":"13","author":"Gu","year":"2011","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.ejvs.2024.07.016_bib26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/gt.2011.21","article-title":"Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study","volume":"18","author":"Henry","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/mt.2013.69","article-title":"Phase 1\/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy","volume":"21","author":"Ajroud-Driss","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acn3.186","article-title":"Double-blind, placebo-controlled study of HGF gene therapy\u00a0in diabetic neuropathy","volume":"2","author":"Kessler","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ejvs.2024.07.016_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ejvs.2015.05.007","article-title":"Clinical safety and preliminary efficacy of plasmid pUDK-HGF expressing human hepatocyte growth factor (HGF) in patients with critical limb ischemia","volume":"50","author":"Cui","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.016_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.gt.3301379","article-title":"Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease","volume":"8","author":"Taniyama","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.gt.3301104","article-title":"Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets","volume":"7","author":"Aoki","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejvs.2024.07.016_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2022.08.007","article-title":"Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): randomized, placebo-controlled, double-blind, phase III clinical trials","volume":"254","author":"Di","year":"2022","journal-title":"Am Heart J"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424006208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424006208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:25:32Z","timestamp":1762028732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588424006208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1078588424006208"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.07.016","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}